Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
批准号:
8745429
负责人:
William Paul
金额:
$10.21万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
1-Phosphatidylinositol 3-KinaseAccountingBiological AssayBiological ProcessCD4 Positive T LymphocytesCandidate Disease GeneCell SeparationCell physiologyCellsChemicalsCyclic AMPCytokine GeneDevelopmentElementsExtinction (Psychology)FutureGene ExpressionGenesGeneticGenomeGenomicsGoalsImmunoglobulinsIn VitroInterleukin-2Lentivirus VectorLibrariesLipidsLymphocyteMediatingMethodsModelingMusParticipantPathway interactionsPatternPeripheralPhosphatidylinositolsPhosphoric Monoester HydrolasesPhosphorylationPlayPopulationPreparationProcessProtein Tyrosine KinaseProtein Tyrosine PhosphataseProto-Oncogene Proteins c-aktPurinergic P1 ReceptorsPuromycinRNA InterferenceReceptor ActivationRegulationResistanceRestRoleScientistScreening procedureSet proteinSignal PathwaySignal TransductionStagingStructureSubfamily lentivirinaeSystemT cell differentiationT-Cell ReceptorT-LymphocyteTechnologyTh1 CellsWorkbasecytokinedeep sequencinginsightinstrumentinterestmemberprotein expressionresponsescreeningsmall hairpin RNAsmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In order to gain a deeper insight into the genetic regulation of cytokine-determined and immunoglobulin/ T cell receptor based signaling in lymphocytes, efforts to use RNA interference (RNAi) technology as a screening tool have been undertaken. An shRNA library consisting of all the mouse phosphatases has been prepared in lentivirus vectors with a puromycin resistance element. Unit scientists have chosen to analyze the importance of phosphatases in peripheral CD4 T cell differentiation to Th1 cells. The model utilized takes advantage of an indicator mouse prepared in the Unit in which ZS-Green expression marks the presence of the master Th1 transcriptional regulator T-bet. When T cells differentiate in vitro into Th1 cells, they express very large amounts of GFP, are easily detectable and can be purified by cell sorting. The initial screen carried out was aimed at determining what phosphatases were important for the expression or the extinction of T-bet during the Th differentiation process. Nave CD4 T cells were exposed to a library of all shRNAs complementary to phosphatases (over 1000 members), The shRNAs were in lentiviruses so that they could be introduced into naive CD4 T cells. The cells were then differentiated under Th1 conditions for 4 days, rested in IL-2 and exposed to puromycin, to eliminate cells that had not incorporated and expressed a member of the library. At this stage the great majority of the cells were already ZS-Green+. The cells were then shifted to Th2 culture conditions. At the end of four additional days of culture , 1/2 of the former Th1 cells were T-bet negative. The T-bet negative and positive cells were purified and the incorporated shRENAs were PCR amplified, utilizing a method to avoid the difficulties resulting from the hairpin structure. The resulting large set of amplified shRNAs were subjected to deep sequencing using an ABI instrument. More than 20 shRNAs were found to be uniquely expressed in the T-bet negative cells and a similar number in the T-bet positives. The technical aspects were shown to be reproducible using PCR amplification with one external and one internal primer. MTMR7 and MTMR9, phosphateses that act on phosphatidyl inositols showed reproducible activity both in repetition of the assay used in screening and in priming done under limiting Th1 conditions. Assays indicate that these phosphatases can effect the PI-3 kinase pathway, as shown by their activity to regulate AKT phosphorylation. MTMR7 normally represses Th2 and Th17 differentiation while MTMR9 represses Th1 differentiation. The differential fnction of these two lipid phosphatases can be accounted for by their pattern of expression. This work emphasis the key role played by phosphatases in regulating lymphocyte differentiation and the power of library based screening in identifying candiates for further analysis.
In parallel, a chemical genomic screen has been undertaken to examine the cpacity of various small molecules from the LOPAC set to alter the rate at which Th17 cells switch to Th1 cells. This has been done using the ZS-Green marker so that small molecules that inhibit or enhance CD4 T cell plasticity have a reasonable likelihood of being detected. Several candidates that inhibit switching have been identified and are now in the course of secondary screening. Among the most interesting are molecules that regulate expression of adenosine receptors, with those that cause activation of receptors and elevation of cAMP repressing switching to Th1 cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin 4
-
批准号:7592157
-
项目类别:
-
资助金额:$162.54万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
-
批准号:7592323
-
项目类别:
-
资助金额:$38.58万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Lymphocyte Dynamics
-
批准号:8336169
-
项目类别:
-
资助金额:$129.17万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Lymphocyte Dynamics
-
批准号:7964486
-
项目类别:
-
资助金额:$118.49万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
-
批准号:8555902
-
项目类别:
-
资助金额:$29.07万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:7732461
-
项目类别:
-
资助金额:$149.35万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
INTERLEUKIN 4 (IL-4)
-
批准号:6098948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Lymphocyte Dynamics
-
批准号:8946366
-
项目类别:
-
资助金额:$99.94万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Lymphocyte Dynamics
-
批准号:8745403
-
项目类别:
-
资助金额:$91.86万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Lymphocyte Dynamics
-
批准号:8156948
-
项目类别:
-
资助金额:$141.57万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
-
批准号:8156977
-
项目类别:
-
资助金额:$46.79万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
-
批准号:8336199
-
项目类别:
-
资助金额:$57.24万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:8946270
-
项目类别:
-
资助金额:$99.94万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Eosinophilic Inflammatory Disease in Mice with Limited TCR Repertoire
-
批准号:7964547
-
项目类别:
-
资助金额:$36.39万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:7964273
-
项目类别:
-
资助金额:$183.41万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
-
批准号:7732622
-
项目类别:
-
资助金额:$33.9万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:8555766
-
项目类别:
-
资助金额:$116.28万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:8336060
-
项目类别:
-
资助金额:$209.96万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:8745303
-
项目类别:
-
资助金额:$102.07万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
Interleukin 4
-
批准号:8156845
-
项目类别:
-
资助金额:$221.41万
-
财政年份:--
-
负责人:William Paul
-
依托单位:
海外基金